Trials / Completed
CompletedNCT02129179
The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Papworth Hospital NHS Foundation Trust · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the effect of glucagon-like peptide-1 on cardiac output and transpulmonary gradient in patients undergoing right heart catheterisation for clinical reasons.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucagon-Like Peptide 1 |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-05-02
- Last updated
- 2018-04-05
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02129179. Inclusion in this directory is not an endorsement.